ArticlePloS one2025
Onsite clinic utilization and adherence in semiconductor employees at chronic disease risk.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe objective of this study was to evaluate the utilization and adherence of onsite clinics and identify the factors influencing them in semiconductor employees at risk of chronic diseases, including hypertension, diabetes, and dyslipidemia.
methodsA cross-sectional study was conducted through a retrospective review of electronic medical records from onsite clinics at a South Korean semiconductor company. The study focused on employees who visited the onsite clinics between 2013 and 2016 due to the risk of chronic diseases including hypertension, diabetes, and dyslipidemia. Descriptive statistics assessed clinic utilization and adherence, while multivariable logistic regression identified influencing factors, adjusted for age, sex, work type, work shift, workplace, specific onsite clinic, diagnosis, and disease duration.
resultsOut of the 39,073 employees examined, 8,837 sought care at onsite clinics for managing chronic disease risks. The majority of these participants were male (88.2%) and predominantly aged in their 30s and 40s (84.6%). Among these individuals, 33.0% visited the clinics five or more times, and 28.5% filled prescriptions on two or more occasions. Chronic diseases were the second most common reason for onsite clinic visits. The average adherence to prescription as measured by the Proportion of Days Covered (PDC) was 0.61, with 40% of individuals showing a high adherence. Notably, older age and employment at workplaces located outside metropolitan areas were significant factors positively associated with both the utilization of onsite clinic services and adherence to prescribed treatments.
conclusionThis study found that onsite clinics within a semiconductor company were actively utilized for managing chronic diseases, particularly among older employees and those in workplaces located in areas where medical access is limited compared to metropolitan areas. These findings highlight the potential role of onsite clinics in enhancing chronic disease management. Future research across a broader range of workplaces could further support and expand these insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.